TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011
TCL Archive SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer. April 22, 2005
TCL Archive Applications Pour In for construction Grants; Three Compete For Mouse Laboratory June 1, 1990
TCL Archive DCT Board Approves Recommendations For Clinical Trials; Some Controversial November 9, 1979